nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—BMPR2—Mesodermal Commitment Pathway—HMGA2—uterine fibroid	0.0156	0.0601	CbGpPWpGaD
Ruxolitinib—MARK2—LKB1 signaling events—ESR1—uterine fibroid	0.0115	0.0443	CbGpPWpGaD
Ruxolitinib—PRKG2—Ca2+ pathway—TNRC6B—uterine fibroid	0.0106	0.0408	CbGpPWpGaD
Ruxolitinib—BMPR2—artery—uterine fibroid	0.00921	0.0124	CbGeAlD
Ruxolitinib—PLK3—nipple—uterine fibroid	0.00808	0.0109	CbGeAlD
Ruxolitinib—PHKG2—Carbohydrate metabolism—HPSE2—uterine fibroid	0.00788	0.0304	CbGpPWpGaD
Ruxolitinib—CAMK1—nipple—uterine fibroid	0.00756	0.0102	CbGeAlD
Ruxolitinib—PRKG2—smooth muscle tissue—uterine fibroid	0.00701	0.00945	CbGeAlD
Ruxolitinib—PLK3—myometrium—uterine fibroid	0.00693	0.00936	CbGeAlD
Ruxolitinib—CAMK1—myometrium—uterine fibroid	0.00649	0.00875	CbGeAlD
Ruxolitinib—PLK1—uterine cervix—uterine fibroid	0.00647	0.00873	CbGeAlD
Ruxolitinib—JAK1—nipple—uterine fibroid	0.0062	0.00837	CbGeAlD
Ruxolitinib—DCLK1—nipple—uterine fibroid	0.0062	0.00837	CbGeAlD
Ruxolitinib—CAMK1D—nipple—uterine fibroid	0.00605	0.00817	CbGeAlD
Ruxolitinib—DAPK2—nipple—uterine fibroid	0.00592	0.00798	CbGeAlD
Ruxolitinib—PLK1—mammalian vulva—uterine fibroid	0.00566	0.00763	CbGeAlD
Ruxolitinib—CLK2—nipple—uterine fibroid	0.00551	0.00744	CbGeAlD
Ruxolitinib—PLK1—uterus—uterine fibroid	0.00539	0.00727	CbGeAlD
Ruxolitinib—PRKG2—beta-catenin independent WNT signaling—TNRC6B—uterine fibroid	0.00535	0.0206	CbGpPWpGaD
Ruxolitinib—JAK1—myometrium—uterine fibroid	0.00532	0.00718	CbGeAlD
Ruxolitinib—DCLK1—myometrium—uterine fibroid	0.00532	0.00718	CbGeAlD
Ruxolitinib—PLK3—decidua—uterine fibroid	0.00514	0.00694	CbGeAlD
Ruxolitinib—CAMK1—uterine cervix—uterine fibroid	0.00505	0.00681	CbGeAlD
Ruxolitinib—PRKCE—female reproductive system—uterine fibroid	0.00504	0.0068	CbGeAlD
Ruxolitinib—PLK3—urethra—uterine fibroid	0.00496	0.00669	CbGeAlD
Ruxolitinib—NUAK2—nipple—uterine fibroid	0.00496	0.00669	CbGeAlD
Ruxolitinib—PLK3—endometrium—uterine fibroid	0.00488	0.00659	CbGeAlD
Ruxolitinib—RET—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.00485	0.0187	CbGpPWpGaD
Ruxolitinib—PLK1—female reproductive system—uterine fibroid	0.00484	0.00654	CbGeAlD
Ruxolitinib—RPS6KA6—female reproductive system—uterine fibroid	0.00484	0.00654	CbGeAlD
Ruxolitinib—CAMK1—decidua—uterine fibroid	0.00481	0.00649	CbGeAlD
Ruxolitinib—DAPK3—myometrium—uterine fibroid	0.00477	0.00644	CbGeAlD
Ruxolitinib—CLK2—myometrium—uterine fibroid	0.00473	0.00638	CbGeAlD
Ruxolitinib—PLK3—mammalian vulva—uterine fibroid	0.00472	0.00637	CbGeAlD
Ruxolitinib—CAMK1—urethra—uterine fibroid	0.00464	0.00626	CbGeAlD
Ruxolitinib—LRRK2—nipple—uterine fibroid	0.0046	0.00621	CbGeAlD
Ruxolitinib—CAMK1—endometrium—uterine fibroid	0.00457	0.00616	CbGeAlD
Ruxolitinib—PLK1—FOXM1 transcription factor network—ESR1—uterine fibroid	0.00456	0.0176	CbGpPWpGaD
Ruxolitinib—PLK3—cardiac atrium—uterine fibroid	0.00452	0.0061	CbGeAlD
Ruxolitinib—BMPR2—myometrium—uterine fibroid	0.00445	0.00601	CbGeAlD
Ruxolitinib—CAMK1—mammalian vulva—uterine fibroid	0.00442	0.00596	CbGeAlD
Ruxolitinib—MAP3K7—nipple—uterine fibroid	0.00418	0.00564	CbGeAlD
Ruxolitinib—TAOK2—urethra—uterine fibroid	0.00417	0.00562	CbGeAlD
Ruxolitinib—DCLK3—vagina—uterine fibroid	0.00415	0.00561	CbGeAlD
Ruxolitinib—DCLK1—uterine cervix—uterine fibroid	0.00414	0.00559	CbGeAlD
Ruxolitinib—JAK1—uterine cervix—uterine fibroid	0.00414	0.00559	CbGeAlD
Ruxolitinib—JAK2—Mesodermal Commitment Pathway—HMGA2—uterine fibroid	0.0041	0.0158	CbGpPWpGaD
Ruxolitinib—TYK2—nipple—uterine fibroid	0.0041	0.00553	CbGeAlD
Ruxolitinib—MKNK2—nipple—uterine fibroid	0.00405	0.00546	CbGeAlD
Ruxolitinib—PLK3—female reproductive system—uterine fibroid	0.00404	0.00546	CbGeAlD
Ruxolitinib—JAK1—smooth muscle tissue—uterine fibroid	0.00402	0.00543	CbGeAlD
Ruxolitinib—CAMK2G—myometrium—uterine fibroid	0.00398	0.00538	CbGeAlD
Ruxolitinib—DAPK2—uterine cervix—uterine fibroid	0.00395	0.00533	CbGeAlD
Ruxolitinib—LRRK2—myometrium—uterine fibroid	0.00395	0.00533	CbGeAlD
Ruxolitinib—JAK1—decidua—uterine fibroid	0.00394	0.00532	CbGeAlD
Ruxolitinib—LTK—female reproductive system—uterine fibroid	0.0039	0.00527	CbGeAlD
Ruxolitinib—PLK3—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.00384	0.0148	CbGpPWpGaD
Ruxolitinib—DCLK1—urethra—uterine fibroid	0.0038	0.00513	CbGeAlD
Ruxolitinib—JAK1—urethra—uterine fibroid	0.0038	0.00513	CbGeAlD
Ruxolitinib—CAMK1—female reproductive system—uterine fibroid	0.00378	0.0051	CbGeAlD
Ruxolitinib—JAK1—endometrium—uterine fibroid	0.00374	0.00505	CbGeAlD
Ruxolitinib—JAK2—nipple—uterine fibroid	0.00373	0.00504	CbGeAlD
Ruxolitinib—CAMK1D—urethra—uterine fibroid	0.00371	0.00501	CbGeAlD
Ruxolitinib—PLK3—female gonad—uterine fibroid	0.00368	0.00497	CbGeAlD
Ruxolitinib—CLK2—uterine cervix—uterine fibroid	0.00368	0.00496	CbGeAlD
Ruxolitinib—MARK2—female reproductive system—uterine fibroid	0.00367	0.00495	CbGeAlD
Ruxolitinib—PLK3—vagina—uterine fibroid	0.00366	0.00493	CbGeAlD
Ruxolitinib—DAPK2—urethra—uterine fibroid	0.00363	0.0049	CbGeAlD
Ruxolitinib—JAK1—mammalian vulva—uterine fibroid	0.00362	0.00489	CbGeAlD
Ruxolitinib—DCLK1—mammalian vulva—uterine fibroid	0.00362	0.00489	CbGeAlD
Ruxolitinib—DAPK3—smooth muscle tissue—uterine fibroid	0.00361	0.00487	CbGeAlD
Ruxolitinib—MAP3K3—nipple—uterine fibroid	0.0036	0.00485	CbGeAlD
Ruxolitinib—MAP3K7—myometrium—uterine fibroid	0.00358	0.00484	CbGeAlD
Ruxolitinib—DAPK2—endometrium—uterine fibroid	0.00357	0.00482	CbGeAlD
Ruxolitinib—DAPK3—decidua—uterine fibroid	0.00354	0.00477	CbGeAlD
Ruxolitinib—CAMK1D—mammalian vulva—uterine fibroid	0.00354	0.00477	CbGeAlD
Ruxolitinib—TYK2—myometrium—uterine fibroid	0.00352	0.00475	CbGeAlD
Ruxolitinib—CLK2—decidua—uterine fibroid	0.0035	0.00473	CbGeAlD
Ruxolitinib—MKNK2—myometrium—uterine fibroid	0.00347	0.00469	CbGeAlD
Ruxolitinib—JAK1—cardiac atrium—uterine fibroid	0.00347	0.00468	CbGeAlD
Ruxolitinib—ROCK1—smooth muscle tissue—uterine fibroid	0.00346	0.00468	CbGeAlD
Ruxolitinib—DAPK2—mammalian vulva—uterine fibroid	0.00346	0.00466	CbGeAlD
Ruxolitinib—JAK1—uterus—uterine fibroid	0.00345	0.00466	CbGeAlD
Ruxolitinib—DCLK1—uterus—uterine fibroid	0.00345	0.00466	CbGeAlD
Ruxolitinib—CAMK1—female gonad—uterine fibroid	0.00344	0.00464	CbGeAlD
Ruxolitinib—CAMK1—vagina—uterine fibroid	0.00342	0.00462	CbGeAlD
Ruxolitinib—DAPK3—urethra—uterine fibroid	0.00341	0.00461	CbGeAlD
Ruxolitinib—CAMK1D—cardiac atrium—uterine fibroid	0.00339	0.00457	CbGeAlD
Ruxolitinib—CLK2—urethra—uterine fibroid	0.00338	0.00456	CbGeAlD
Ruxolitinib—BMPR2—smooth muscle tissue—uterine fibroid	0.00337	0.00454	CbGeAlD
Ruxolitinib—DAPK3—endometrium—uterine fibroid	0.00336	0.00453	CbGeAlD
Ruxolitinib—JAK2—Nuclear signaling by ERBB4—PGR—uterine fibroid	0.00335	0.013	CbGpPWpGaD
Ruxolitinib—CLK2—endometrium—uterine fibroid	0.00333	0.00449	CbGeAlD
Ruxolitinib—DYRK1A—decidua—uterine fibroid	0.00331	0.00447	CbGeAlD
Ruxolitinib—NUAK2—uterine cervix—uterine fibroid	0.00331	0.00447	CbGeAlD
Ruxolitinib—DAPK2—cardiac atrium—uterine fibroid	0.00331	0.00447	CbGeAlD
Ruxolitinib—BMPR2—decidua—uterine fibroid	0.0033	0.00445	CbGeAlD
Ruxolitinib—TAOK3—nipple—uterine fibroid	0.00328	0.00442	CbGeAlD
Ruxolitinib—DAPK3—mammalian vulva—uterine fibroid	0.00325	0.00438	CbGeAlD
Ruxolitinib—CLK2—mammalian vulva—uterine fibroid	0.00322	0.00434	CbGeAlD
Ruxolitinib—JAK2—myometrium—uterine fibroid	0.0032	0.00432	CbGeAlD
Ruxolitinib—CAMK2G—Cellular responses to stress—HMGA2—uterine fibroid	0.0032	0.0124	CbGpPWpGaD
Ruxolitinib—BMPR2—urethra—uterine fibroid	0.00318	0.0043	CbGeAlD
Ruxolitinib—NUAK2—decidua—uterine fibroid	0.00315	0.00426	CbGeAlD
Ruxolitinib—JAK3—female reproductive system—uterine fibroid	0.00312	0.00421	CbGeAlD
Ruxolitinib—DAPK3—cardiac atrium—uterine fibroid	0.00311	0.0042	CbGeAlD
Ruxolitinib—JAK1—female reproductive system—uterine fibroid	0.0031	0.00419	CbGeAlD
Ruxolitinib—CAMK2G—uterine cervix—uterine fibroid	0.0031	0.00418	CbGeAlD
Ruxolitinib—BMP2K—uterine cervix—uterine fibroid	0.0031	0.00418	CbGeAlD
Ruxolitinib—DAPK3—uterus—uterine fibroid	0.0031	0.00418	CbGeAlD
Ruxolitinib—TAOK2—female gonad—uterine fibroid	0.00309	0.00417	CbGeAlD
Ruxolitinib—MAP3K3—myometrium—uterine fibroid	0.00308	0.00416	CbGeAlD
Ruxolitinib—PLK4—female reproductive system—uterine fibroid	0.00308	0.00416	CbGeAlD
Ruxolitinib—CLK2—cardiac atrium—uterine fibroid	0.00308	0.00416	CbGeAlD
Ruxolitinib—TAOK2—vagina—uterine fibroid	0.00307	0.00415	CbGeAlD
Ruxolitinib—LRRK2—uterine cervix—uterine fibroid	0.00307	0.00415	CbGeAlD
Ruxolitinib—MAP3K7—Ca2+ pathway—TNRC6B—uterine fibroid	0.00303	0.0117	CbGpPWpGaD
Ruxolitinib—PHKG2—female reproductive system—uterine fibroid	0.00301	0.00406	CbGeAlD
Ruxolitinib—NUAK2—endometrium—uterine fibroid	0.00299	0.00404	CbGeAlD
Ruxolitinib—BMP2K—decidua—uterine fibroid	0.00295	0.00399	CbGeAlD
Ruxolitinib—LRRK2—decidua—uterine fibroid	0.00293	0.00395	CbGeAlD
Ruxolitinib—STK16—female reproductive system—uterine fibroid	0.00291	0.00393	CbGeAlD
Ruxolitinib—BMPR2—cardiac atrium—uterine fibroid	0.0029	0.00392	CbGeAlD
Ruxolitinib—HIPK2—female reproductive system—uterine fibroid	0.0029	0.00391	CbGeAlD
Ruxolitinib—NUAK2—mammalian vulva—uterine fibroid	0.0029	0.00391	CbGeAlD
Ruxolitinib—BMPR2—uterus—uterine fibroid	0.00289	0.0039	CbGeAlD
Ruxolitinib—PRKCE—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00286	0.011	CbGpPWpGaD
Ruxolitinib—CAMK2G—urethra—uterine fibroid	0.00285	0.00384	CbGeAlD
Ruxolitinib—JAK3—female gonad—uterine fibroid	0.00284	0.00383	CbGeAlD
Ruxolitinib—MAP3K19—female reproductive system—uterine fibroid	0.00284	0.00383	CbGeAlD
Ruxolitinib—PRKG2—Signaling by Wnt—TNRC6B—uterine fibroid	0.00283	0.0109	CbGpPWpGaD
Ruxolitinib—LRRK2—urethra—uterine fibroid	0.00282	0.00381	CbGeAlD
Ruxolitinib—JAK1—female gonad—uterine fibroid	0.00282	0.00381	CbGeAlD
Ruxolitinib—MAP3K2—uterine cervix—uterine fibroid	0.00281	0.0038	CbGeAlD
Ruxolitinib—TAOK3—myometrium—uterine fibroid	0.00281	0.0038	CbGeAlD
Ruxolitinib—JAK1—vagina—uterine fibroid	0.00281	0.00379	CbGeAlD
Ruxolitinib—DCLK1—vagina—uterine fibroid	0.00281	0.00379	CbGeAlD
Ruxolitinib—CAMK2G—endometrium—uterine fibroid	0.0028	0.00378	CbGeAlD
Ruxolitinib—BMP2K—endometrium—uterine fibroid	0.0028	0.00378	CbGeAlD
Ruxolitinib—MAP3K7—uterine cervix—uterine fibroid	0.00279	0.00376	CbGeAlD
Ruxolitinib—DAPK3—female reproductive system—uterine fibroid	0.00278	0.00375	CbGeAlD
Ruxolitinib—LRRK2—endometrium—uterine fibroid	0.00278	0.00375	CbGeAlD
Ruxolitinib—CLK2—female reproductive system—uterine fibroid	0.00276	0.00372	CbGeAlD
Ruxolitinib—CAMK1D—female gonad—uterine fibroid	0.00276	0.00372	CbGeAlD
Ruxolitinib—PHKG2—female gonad—uterine fibroid	0.00274	0.0037	CbGeAlD
Ruxolitinib—CAMK1D—vagina—uterine fibroid	0.00274	0.0037	CbGeAlD
Ruxolitinib—TYK2—uterine cervix—uterine fibroid	0.00274	0.00369	CbGeAlD
Ruxolitinib—MAP3K7—smooth muscle tissue—uterine fibroid	0.00271	0.00366	CbGeAlD
Ruxolitinib—HIPK2—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.0027	0.0104	CbGpPWpGaD
Ruxolitinib—IRAK1—uterine cervix—uterine fibroid	0.0027	0.00365	CbGeAlD
Ruxolitinib—MKNK2—uterine cervix—uterine fibroid	0.0027	0.00365	CbGeAlD
Ruxolitinib—DAPK2—female gonad—uterine fibroid	0.00269	0.00363	CbGeAlD
Ruxolitinib—LRRK2—mammalian vulva—uterine fibroid	0.00269	0.00363	CbGeAlD
Ruxolitinib—PRKCE—Downstream signal transduction—TNRC6B—uterine fibroid	0.00268	0.0104	CbGpPWpGaD
Ruxolitinib—DAPK2—vagina—uterine fibroid	0.00268	0.00361	CbGeAlD
Ruxolitinib—ROCK1—female reproductive system—uterine fibroid	0.00267	0.00361	CbGeAlD
Ruxolitinib—PRKCE—Signaling by FGFR—TNRC6B—uterine fibroid	0.00267	0.0103	CbGpPWpGaD
Ruxolitinib—TYK2—smooth muscle tissue—uterine fibroid	0.00266	0.00359	CbGeAlD
Ruxolitinib—PRKCE—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00266	0.0103	CbGpPWpGaD
Ruxolitinib—MAP3K7—decidua—uterine fibroid	0.00266	0.00358	CbGeAlD
Ruxolitinib—STK16—female gonad—uterine fibroid	0.00265	0.00358	CbGeAlD
Ruxolitinib—PRKCE—DAP12 signaling—TNRC6B—uterine fibroid	0.00264	0.0102	CbGpPWpGaD
Ruxolitinib—HIPK2—female gonad—uterine fibroid	0.00264	0.00356	CbGeAlD
Ruxolitinib—STK16—vagina—uterine fibroid	0.00263	0.00355	CbGeAlD
Ruxolitinib—MKNK2—smooth muscle tissue—uterine fibroid	0.00263	0.00354	CbGeAlD
Ruxolitinib—IRAK1—smooth muscle tissue—uterine fibroid	0.00263	0.00354	CbGeAlD
Ruxolitinib—TYK2—decidua—uterine fibroid	0.00261	0.00352	CbGeAlD
Ruxolitinib—DYRK1A—female reproductive system—uterine fibroid	0.00261	0.00352	CbGeAlD
Ruxolitinib—BMPR2—female reproductive system—uterine fibroid	0.00259	0.0035	CbGeAlD
Ruxolitinib—CAMK2G—uterus—uterine fibroid	0.00258	0.00349	CbGeAlD
Ruxolitinib—MKNK2—decidua—uterine fibroid	0.00257	0.00347	CbGeAlD
Ruxolitinib—IRAK1—decidua—uterine fibroid	0.00257	0.00347	CbGeAlD
Ruxolitinib—MAP3K7—urethra—uterine fibroid	0.00256	0.00346	CbGeAlD
Ruxolitinib—DAPK3—female gonad—uterine fibroid	0.00253	0.00342	CbGeAlD
Ruxolitinib—MAP3K7—endometrium—uterine fibroid	0.00252	0.0034	CbGeAlD
Ruxolitinib—HIPK2—Generic Transcription Pathway—MED12—uterine fibroid	0.00252	0.00971	CbGpPWpGaD
Ruxolitinib—DAPK3—vagina—uterine fibroid	0.00252	0.0034	CbGeAlD
Ruxolitinib—TYK2—urethra—uterine fibroid	0.00252	0.0034	CbGeAlD
Ruxolitinib—RET—decidua—uterine fibroid	0.00251	0.00339	CbGeAlD
Ruxolitinib—CLK2—female gonad—uterine fibroid	0.00251	0.00338	CbGeAlD
Ruxolitinib—CLK2—vagina—uterine fibroid	0.00249	0.00336	CbGeAlD
Ruxolitinib—JAK2—uterine cervix—uterine fibroid	0.00249	0.00336	CbGeAlD
Ruxolitinib—PRKCE—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00249	0.0096	CbGpPWpGaD
Ruxolitinib—PRKCE—DAP12 interactions—TNRC6B—uterine fibroid	0.00249	0.0096	CbGpPWpGaD
Ruxolitinib—MKNK2—urethra—uterine fibroid	0.00248	0.00335	CbGeAlD
Ruxolitinib—TYK2—endometrium—uterine fibroid	0.00248	0.00334	CbGeAlD
Ruxolitinib—GRK1—Disease—HPSE2—uterine fibroid	0.00247	0.00953	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by EGFR—TNRC6B—uterine fibroid	0.00247	0.00952	CbGpPWpGaD
Ruxolitinib—MKNK2—endometrium—uterine fibroid	0.00244	0.0033	CbGeAlD
Ruxolitinib—PRKCE—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00244	0.00943	CbGpPWpGaD
Ruxolitinib—MAP3K7—mammalian vulva—uterine fibroid	0.00244	0.00329	CbGeAlD
Ruxolitinib—PRKCE—Signaling by PDGF—TNRC6B—uterine fibroid	0.00243	0.00939	CbGpPWpGaD
Ruxolitinib—ROCK1—female gonad—uterine fibroid	0.00243	0.00328	CbGeAlD
Ruxolitinib—JAK2—smooth muscle tissue—uterine fibroid	0.00242	0.00327	CbGeAlD
Ruxolitinib—MAP3K3—uterine cervix—uterine fibroid	0.0024	0.00324	CbGeAlD
Ruxolitinib—TYK2—mammalian vulva—uterine fibroid	0.0024	0.00323	CbGeAlD
Ruxolitinib—JAK2—decidua—uterine fibroid	0.00237	0.0032	CbGeAlD
Ruxolitinib—DYRK1A—female gonad—uterine fibroid	0.00237	0.0032	CbGeAlD
Ruxolitinib—MKNK2—mammalian vulva—uterine fibroid	0.00236	0.00319	CbGeAlD
Ruxolitinib—IRAK1—mammalian vulva—uterine fibroid	0.00236	0.00319	CbGeAlD
Ruxolitinib—BMPR2—female gonad—uterine fibroid	0.00236	0.00319	CbGeAlD
Ruxolitinib—BMPR2—vagina—uterine fibroid	0.00235	0.00317	CbGeAlD
Ruxolitinib—MAP3K2—uterus—uterine fibroid	0.00235	0.00317	CbGeAlD
Ruxolitinib—MAP3K7—cardiac atrium—uterine fibroid	0.00234	0.00315	CbGeAlD
Ruxolitinib—MAP3K7—uterus—uterine fibroid	0.00232	0.00314	CbGeAlD
Ruxolitinib—CAMK2G—female reproductive system—uterine fibroid	0.00232	0.00313	CbGeAlD
Ruxolitinib—BMP2K—female reproductive system—uterine fibroid	0.00232	0.00313	CbGeAlD
Ruxolitinib—LRRK2—female reproductive system—uterine fibroid	0.0023	0.00311	CbGeAlD
Ruxolitinib—BMPR2—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.0023	0.00888	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—MED12—uterine fibroid	0.00229	0.00886	CbGpPWpGaD
Ruxolitinib—TYK2—cardiac atrium—uterine fibroid	0.00229	0.0031	CbGeAlD
Ruxolitinib—JAK2—urethra—uterine fibroid	0.00229	0.00309	CbGeAlD
Ruxolitinib—MAP3K3—decidua—uterine fibroid	0.00229	0.00309	CbGeAlD
Ruxolitinib—TYK2—uterus—uterine fibroid	0.00228	0.00308	CbGeAlD
Ruxolitinib—MKNK2—cardiac atrium—uterine fibroid	0.00226	0.00306	CbGeAlD
Ruxolitinib—NUAK2—female gonad—uterine fibroid	0.00226	0.00305	CbGeAlD
Ruxolitinib—JAK2—endometrium—uterine fibroid	0.00225	0.00304	CbGeAlD
Ruxolitinib—MKNK2—uterus—uterine fibroid	0.00225	0.00304	CbGeAlD
Ruxolitinib—NUAK2—vagina—uterine fibroid	0.00224	0.00303	CbGeAlD
Ruxolitinib—PHKG2—Disease—HPSE2—uterine fibroid	0.00223	0.00862	CbGpPWpGaD
Ruxolitinib—MAP3K3—urethra—uterine fibroid	0.00221	0.00298	CbGeAlD
Ruxolitinib—PRKCE—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.0022	0.00851	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—HPSE2—uterine fibroid	0.0022	0.00849	CbGpPWpGaD
Ruxolitinib—TAOK3—uterine cervix—uterine fibroid	0.00219	0.00295	CbGeAlD
Ruxolitinib—JAK2—mammalian vulva—uterine fibroid	0.00218	0.00294	CbGeAlD
Ruxolitinib—MAP3K3—endometrium—uterine fibroid	0.00217	0.00293	CbGeAlD
Ruxolitinib—JAK1—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00217	0.00836	CbGpPWpGaD
Ruxolitinib—CAMK2G—female gonad—uterine fibroid	0.00211	0.00285	CbGeAlD
Ruxolitinib—BMP2K—female gonad—uterine fibroid	0.00211	0.00285	CbGeAlD
Ruxolitinib—MAP3K2—female reproductive system—uterine fibroid	0.00211	0.00285	CbGeAlD
Ruxolitinib—MAP3K3—mammalian vulva—uterine fibroid	0.0021	0.00283	CbGeAlD
Ruxolitinib—CAMK2G—vagina—uterine fibroid	0.0021	0.00283	CbGeAlD
Ruxolitinib—BMP2K—vagina—uterine fibroid	0.0021	0.00283	CbGeAlD
Ruxolitinib—LRRK2—female gonad—uterine fibroid	0.00209	0.00283	CbGeAlD
Ruxolitinib—JAK2—cardiac atrium—uterine fibroid	0.00209	0.00282	CbGeAlD
Ruxolitinib—TAOK3—decidua—uterine fibroid	0.00209	0.00281	CbGeAlD
Ruxolitinib—HIPK2—Generic Transcription Pathway—PGR—uterine fibroid	0.00209	0.00805	CbGpPWpGaD
Ruxolitinib—LRRK2—vagina—uterine fibroid	0.00208	0.00281	CbGeAlD
Ruxolitinib—JAK1—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00207	0.008	CbGpPWpGaD
Ruxolitinib—TYK2—female reproductive system—uterine fibroid	0.00205	0.00277	CbGeAlD
Ruxolitinib—JAK1—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00204	0.00788	CbGpPWpGaD
Ruxolitinib—MKNK2—female reproductive system—uterine fibroid	0.00202	0.00273	CbGeAlD
Ruxolitinib—IRAK1—female reproductive system—uterine fibroid	0.00202	0.00273	CbGeAlD
Ruxolitinib—JAK1—Signaling by ERBB4—PGR—uterine fibroid	0.00202	0.0078	CbGpPWpGaD
Ruxolitinib—TAOK3—urethra—uterine fibroid	0.00201	0.00271	CbGeAlD
Ruxolitinib—MAP3K3—cardiac atrium—uterine fibroid	0.00201	0.00271	CbGeAlD
Ruxolitinib—TAOK3—endometrium—uterine fibroid	0.00198	0.00267	CbGeAlD
Ruxolitinib—JAK1—Downstream signal transduction—TNRC6B—uterine fibroid	0.00195	0.00752	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by FGFR—TNRC6B—uterine fibroid	0.00194	0.00748	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00193	0.00745	CbGpPWpGaD
Ruxolitinib—JAK1—DAP12 signaling—TNRC6B—uterine fibroid	0.00192	0.00741	CbGpPWpGaD
Ruxolitinib—MAP3K2—female gonad—uterine fibroid	0.00192	0.00259	CbGeAlD
Ruxolitinib—TAOK3—mammalian vulva—uterine fibroid	0.00191	0.00258	CbGeAlD
Ruxolitinib—MAP3K7—female gonad—uterine fibroid	0.0019	0.00257	CbGeAlD
Ruxolitinib—JAK1—Leptin signaling pathway—ESR1—uterine fibroid	0.0019	0.00733	CbGpPWpGaD
Ruxolitinib—MAP3K7—vagina—uterine fibroid	0.00189	0.00255	CbGeAlD
Ruxolitinib—PHKG2—Metabolism—HPSE2—uterine fibroid	0.00187	0.00722	CbGpPWpGaD
Ruxolitinib—TYK2—female gonad—uterine fibroid	0.00187	0.00252	CbGeAlD
Ruxolitinib—ROCK1—Leptin signaling pathway—ESR1—uterine fibroid	0.00187	0.0072	CbGpPWpGaD
Ruxolitinib—JAK2—female reproductive system—uterine fibroid	0.00187	0.00252	CbGeAlD
Ruxolitinib—TYK2—vagina—uterine fibroid	0.00186	0.0025	CbGeAlD
Ruxolitinib—MKNK2—female gonad—uterine fibroid	0.00184	0.00249	CbGeAlD
Ruxolitinib—IRAK1—female gonad—uterine fibroid	0.00184	0.00249	CbGeAlD
Ruxolitinib—TAOK3—cardiac atrium—uterine fibroid	0.00183	0.00247	CbGeAlD
Ruxolitinib—MKNK2—vagina—uterine fibroid	0.00183	0.00247	CbGeAlD
Ruxolitinib—TAOK3—uterus—uterine fibroid	0.00182	0.00246	CbGeAlD
Ruxolitinib—JAK1—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00181	0.00697	CbGpPWpGaD
Ruxolitinib—JAK1—DAP12 interactions—TNRC6B—uterine fibroid	0.00181	0.00697	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00181	0.00697	CbGpPWpGaD
Ruxolitinib—MAP3K3—female reproductive system—uterine fibroid	0.0018	0.00243	CbGeAlD
Ruxolitinib—JAK2—Nuclear signaling by ERBB4—ESR1—uterine fibroid	0.00179	0.00692	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by EGFR—TNRC6B—uterine fibroid	0.00179	0.00691	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00177	0.00685	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by PDGF—TNRC6B—uterine fibroid	0.00177	0.00682	CbGpPWpGaD
Ruxolitinib—JAK2—female gonad—uterine fibroid	0.0017	0.00229	CbGeAlD
Ruxolitinib—PRKCE—Signaling by NGF—TNRC6B—uterine fibroid	0.00169	0.00654	CbGpPWpGaD
Ruxolitinib—JAK2—vagina—uterine fibroid	0.00169	0.00228	CbGeAlD
Ruxolitinib—CAMK2G—Cellular responses to stress—TNRC6B—uterine fibroid	0.00165	0.00639	CbGpPWpGaD
Ruxolitinib—TAOK3—female reproductive system—uterine fibroid	0.00164	0.00221	CbGeAlD
Ruxolitinib—PLK1—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.00164	0.00633	CbGpPWpGaD
Ruxolitinib—MAP3K3—female gonad—uterine fibroid	0.00164	0.00221	CbGeAlD
Ruxolitinib—MAP3K3—vagina—uterine fibroid	0.00163	0.0022	CbGeAlD
Ruxolitinib—JAK1—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.0016	0.00618	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.0016	0.00617	CbGpPWpGaD
Ruxolitinib—MAP3K7—beta-catenin independent WNT signaling—TNRC6B—uterine fibroid	0.00153	0.00592	CbGpPWpGaD
Ruxolitinib—TYK2—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00153	0.00591	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00151	0.00581	CbGpPWpGaD
Ruxolitinib—TAOK3—female gonad—uterine fibroid	0.00149	0.00201	CbGeAlD
Ruxolitinib—TYK2—Signaling by ERBB4—PGR—uterine fibroid	0.00149	0.00576	CbGpPWpGaD
Ruxolitinib—TAOK3—vagina—uterine fibroid	0.00148	0.002	CbGeAlD
Ruxolitinib—PRKCE—Disease—HPSE2—uterine fibroid	0.00145	0.0056	CbGpPWpGaD
Ruxolitinib—TYK2—Downstream signal transduction—TNRC6B—uterine fibroid	0.00144	0.00555	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by FGFR—TNRC6B—uterine fibroid	0.00143	0.00553	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00142	0.0055	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 signaling—TNRC6B—uterine fibroid	0.00142	0.00547	CbGpPWpGaD
Ruxolitinib—PLK1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.00136	0.00524	CbGpPWpGaD
Ruxolitinib—MAP3K7—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00135	0.00523	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 interactions—TNRC6B—uterine fibroid	0.00133	0.00515	CbGpPWpGaD
Ruxolitinib—TYK2—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00133	0.00515	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00133	0.00515	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR—TNRC6B—uterine fibroid	0.00132	0.0051	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00131	0.00506	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by PDGF—TNRC6B—uterine fibroid	0.0013	0.00503	CbGpPWpGaD
Ruxolitinib—MAP3K7—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00129	0.00499	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by NGF—TNRC6B—uterine fibroid	0.00123	0.00475	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00121	0.00468	CbGpPWpGaD
Ruxolitinib—HIPK2—Gene Expression—MED12—uterine fibroid	0.00121	0.00468	CbGpPWpGaD
Ruxolitinib—MAP3K7—B Cell Activation—TNRC6B—uterine fibroid	0.0012	0.00462	CbGpPWpGaD
Ruxolitinib—TYK2—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00118	0.00456	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00116	0.00448	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00114	0.00441	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB4—PGR—uterine fibroid	0.00113	0.00436	CbGpPWpGaD
Ruxolitinib—HIPK2—Generic Transcription Pathway—ESR1—uterine fibroid	0.00111	0.0043	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signal transduction—TNRC6B—uterine fibroid	0.00109	0.00421	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR—TNRC6B—uterine fibroid	0.00108	0.00419	CbGpPWpGaD
Ruxolitinib—JAK1—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.00108	0.00419	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00108	0.00417	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by ERBB4—ESR1—uterine fibroid	0.00108	0.00416	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 signaling—TNRC6B—uterine fibroid	0.00107	0.00415	CbGpPWpGaD
Ruxolitinib—JAK2—Leptin signaling pathway—ESR1—uterine fibroid	0.00106	0.0041	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—HPSE2—uterine fibroid	0.00105	0.00406	CbGpPWpGaD
Ruxolitinib—HIPK2—Gene Expression—TNRC6B—uterine fibroid	0.00101	0.00391	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 interactions—TNRC6B—uterine fibroid	0.00101	0.0039	CbGpPWpGaD
Ruxolitinib—JAK2—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00101	0.0039	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00101	0.0039	CbGpPWpGaD
Ruxolitinib—HIPK2—Gene Expression—PGR—uterine fibroid	0.001	0.00388	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR—TNRC6B—uterine fibroid	0.001	0.00387	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000993	0.00383	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by PDGF—TNRC6B—uterine fibroid	0.000988	0.00382	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—TNRC6B—uterine fibroid	0.000967	0.00373	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—MED12—uterine fibroid	0.000949	0.00366	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—MED12—uterine fibroid	0.000942	0.00364	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—TNRC6B—uterine fibroid	0.000936	0.00361	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—MED12—uterine fibroid	0.000934	0.0036	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—TNRC6B—uterine fibroid	0.000908	0.00351	CbGpPWpGaD
Ruxolitinib—JAK2—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000895	0.00346	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—TNRC6B—uterine fibroid	0.000885	0.00342	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling by Wnt—TNRC6B—uterine fibroid	0.000811	0.00313	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—MED12—uterine fibroid	0.000801	0.00309	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—TNRC6B—uterine fibroid	0.000801	0.00309	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by ERBB4—ESR1—uterine fibroid	0.000796	0.00307	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—CYP17A1—uterine fibroid	0.000789	0.00304	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—HPSE2—uterine fibroid	0.000777	0.003	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—TNRC6B—uterine fibroid	0.000702	0.00271	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—MED12—uterine fibroid	0.000701	0.00271	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—TNRC6B—uterine fibroid	0.000688	0.00266	CbGpPWpGaD
Ruxolitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000679	0.00262	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—CYP17A1—uterine fibroid	0.00067	0.00259	CbGpPWpGaD
Ruxolitinib—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00067	0.00259	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—TNRC6B—uterine fibroid	0.000659	0.00255	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—PGR—uterine fibroid	0.000653	0.00252	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—TNRC6B—uterine fibroid	0.00062	0.00239	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—PGR—uterine fibroid	0.000614	0.00237	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB4—ESR1—uterine fibroid	0.000603	0.00233	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—HPSE2—uterine fibroid	0.000589	0.00227	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—TNRC6B—uterine fibroid	0.000563	0.00217	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TNRC6B—uterine fibroid	0.000561	0.00216	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—PGR—uterine fibroid	0.000555	0.00214	CbGpPWpGaD
Ruxolitinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00055	0.00212	CbGpPWpGaD
Ruxolitinib—HIPK2—Gene Expression—ESR1—uterine fibroid	0.000536	0.00207	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—TNRC6B—uterine fibroid	0.000534	0.00206	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—MED12—uterine fibroid	0.000531	0.00205	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—TNRC6B—uterine fibroid	0.00052	0.00201	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—TNRC6B—uterine fibroid	0.000518	0.002	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—TNRC6B—uterine fibroid	0.000516	0.00199	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—TNRC6B—uterine fibroid	0.000504	0.00194	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—TNRC6B—uterine fibroid	0.000502	0.00194	CbGpPWpGaD
Ruxolitinib—CYP3A4—female reproductive system—uterine fibroid	0.000498	0.000672	CbGeAlD
Ruxolitinib—MAP3K7—Adaptive Immune System—TNRC6B—uterine fibroid	0.000483	0.00186	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—TNRC6B—uterine fibroid	0.000475	0.00183	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—TNRC6B—uterine fibroid	0.000409	0.00158	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—TNRC6B—uterine fibroid	0.000393	0.00152	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—TNRC6B—uterine fibroid	0.000377	0.00146	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TNRC6B—uterine fibroid	0.000364	0.00141	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—PGR—uterine fibroid	0.00036	0.00139	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—ESR1—uterine fibroid	0.000349	0.00135	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—ESR1—uterine fibroid	0.000328	0.00127	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—TNRC6B—uterine fibroid	0.000311	0.0012	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TNRC6B—uterine fibroid	0.000307	0.00119	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—PGR—uterine fibroid	0.000304	0.00117	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—TNRC6B—uterine fibroid	0.000302	0.00116	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—ESR1—uterine fibroid	0.000296	0.00114	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—TNRC6B—uterine fibroid	0.000293	0.00113	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	0.000292	0.00113	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000288	0.00111	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TNRC6B—uterine fibroid	0.000279	0.00108	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TNRC6B—uterine fibroid	0.000264	0.00102	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—PGR—uterine fibroid	0.000262	0.00101	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TNRC6B—uterine fibroid	0.00026	0.001	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—PGR—uterine fibroid	0.000257	0.000993	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—TNRC6B—uterine fibroid	0.000229	0.000883	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TNRC6B—uterine fibroid	0.000211	0.000815	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TNRC6B—uterine fibroid	0.000201	0.000776	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PGR—uterine fibroid	0.000199	0.000768	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TNRC6B—uterine fibroid	0.000195	0.000753	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PGR—uterine fibroid	0.000193	0.000746	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—ESR1—uterine fibroid	0.000192	0.000743	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TNRC6B—uterine fibroid	0.000189	0.00073	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PGR—uterine fibroid	0.000187	0.000723	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—ESR1—uterine fibroid	0.000162	0.000627	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TNRC6B—uterine fibroid	0.000148	0.000571	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PGR—uterine fibroid	0.000146	0.000565	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—ESR1—uterine fibroid	0.00014	0.000539	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HPSE2—uterine fibroid	0.000139	0.000538	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—ESR1—uterine fibroid	0.000137	0.00053	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ESR1—uterine fibroid	0.000106	0.00041	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ESR1—uterine fibroid	0.000103	0.000398	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ESR1—uterine fibroid	0.0001	0.000386	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ESR1—uterine fibroid	7.82e-05	0.000302	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MED12—uterine fibroid	5.97e-05	0.00023	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP17A1—uterine fibroid	5e-05	0.000193	CbGpPWpGaD
